Emergency Medicine
Treatments for mild COVID-19: Cochrane evidence.
17 Mar, 2022 | 09:17h | UTCTreatments for mild COVID-19: Cochrane evidence – Cochrane Library
Malignant Hypertension: Current perspectives and challenges.
17 Mar, 2022 | 09:03h | UTC
Open-Label, multicenter study of Flecainide Acetate oral inhalation solution for acute conversion of recent-onset, symptomatic atrial fibrillation to sinus rhythm.
17 Mar, 2022 | 09:01h | UTC
Commentary on Twitter
Inhalation of flecainide simply converts many episodes of recent onset atrial fibrillation #AHAJournals #HeartMonthhttps://t.co/vNXx4fKy2u pic.twitter.com/UNGA9DX3qM
— CircEP (@CirculationEP) February 25, 2022
Happy TRALIdays: An overview of trauma resuscitation and transfusion complications.
17 Mar, 2022 | 08:08h | UTCHappy TRALIdays: An Overview of Trauma Resuscitation and Transfusion Complications – emDocs
Review: Role of imaging in rare COVID-19 vaccine multiorgan complications.
16 Mar, 2022 | 10:00h | UTCRole of imaging in rare COVID-19 vaccine multiorgan complications – Insights into Imaging
Management of respiratory failure: ventilator management 101 and noninvasive ventilation.
14 Mar, 2022 | 00:45h | UTC
Review: Drug-induced acute kidney injury.
14 Mar, 2022 | 00:48h | UTCDrug-Induced Acute Kidney Injury – Clinical Journal of the American Society of Nephrology
Efficacy and safety of non-operative management of uncomplicated acute appendicitis compared to appendectomy: an umbrella review of systematic reviews and meta-analyses.
11 Mar, 2022 | 09:49h | UTCRelated:
Review: Diagnosis of uncomplicated and complicated appendicitis in adults.
A Randomized trial comparing antibiotics with appendectomy for appendicitis
RCT: In patients with refractory out-of-hospital cardiac arrest, a strategy of intra-arrest transport, extracorporeal cardiopulmonary resuscitation, and immediate invasive assessment did not significantly improve survival with a favorable neurological outcome (OR 1.63; 95% CI 0.93 to 2.85; P = .09).
10 Mar, 2022 | 10:57h | UTCEffect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentary: Early Invasive Therapy for Out-of-Hospital Cardiac Arrest – American College of Cardiology
Commentary on Twitter
https://twitter.com/JAMA_current/status/1496183512025677829
Perspective: Once viewed as a promising COVID-19 treatment, convalescent plasma falls out of favor.
10 Mar, 2022 | 10:47h | UTCOnce Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor – JAMA
RCT: The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure.
9 Mar, 2022 | 10:04h | UTC
ACS Best Practice Guidelines: Spine injury.
9 Mar, 2022 | 10:00h | UTCSpine Injury – American College of Surgeons
News Release: New guidelines will help trauma centers treat spinal injury patients
RCT: In patients with trauma-related hemorrhagic shock receiving prehospital care, there was no benefit from resuscitation with blood products compared to 0.9% sodium chloride.
9 Mar, 2022 | 09:55h | UTCInvited commentary: Prehospital blood transfusion: who benefits? – The Lancet Haematology
Commentary on Twitter
NEW research—resuscitation with blood products in patients with trauma-related haemorrhagic shock receiving prehospital care: results of #RePHILL, a randomised, controlled, phase 3 trial #openaccess #EmergencyMedicine 🚑🩸https://t.co/Ci0lMMCryX pic.twitter.com/iWEtV12N1r
— The Lancet Haematology (@TheLancetHaem) March 8, 2022
Study shows the number of covid-19 infections missed by lateral flow tests “substantial enough to be of clinical importance”.
8 Mar, 2022 | 08:57h | UTCOriginal Study: SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis – The BMJ
Commentaries:
Fighting against sudden cardiac death: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention.
8 Mar, 2022 | 08:39h | UTC
Commentary on Twitter
Fighting against #SuddenCardiacDeath: need for a paradigm shift—Adding near-term prevention and pre-emptive action to long-term prevention https://t.co/5xLeUAB9QD @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/IGzZ8dmLd6
— European Society of Cardiology Journals (@ESC_Journals) March 7, 2022
Case report: Nonthrombotic pulmonary embolism secondary to cyanoacrylate embolization of gastric varices.
8 Mar, 2022 | 08:35h | UTC
RCT: In patients with stable chest pain with intermediate pretest probability of obstructive coronary artery disease, an initial diagnostic imaging strategy based on CT angiography resulted in similar risks of major adverse cardiovascular events compared to invasive coronary angiography.
7 Mar, 2022 | 00:55h | UTCCT or Invasive Coronary Angiography in Stable Chest Pain – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain – TCTMD
Commentary on Twitter
Among patients referred for invasive coronary angiography because of stable chest pain and intermediate pretest probability of CAD, the risk of major adverse CV events was similar in the CT group and the ICA group. #ECR22 https://t.co/KnuQo0juxE pic.twitter.com/Sf70dqfgKP
— NEJM (@NEJM) March 4, 2022
RCT: Anterior–lateral electrode position is more effective compared to anterior–posterior electrode position for cardioverting atrial fibrillation.
7 Mar, 2022 | 00:45h | UTCCommentary: Anterior-Lateral or Anterior-Posterior Pads for A-fib Cardioversion? – JournalFeed
Commentary on Twitter
#OriginalResearch In this multicenter RCT of 468 patients, anterior-lateral electrode position was more effective than anterior-posterior electrode position for ⚡cardioversion of #Afib #AHAJournalshttps://t.co/XJlxe7e7Ed pic.twitter.com/hA4wGb6Pak
— Circulation (@CircAHA) November 24, 2021
Systematic Review: Anticoagulants for people hospitalized with COVID‐19.
7 Mar, 2022 | 00:48h | UTCAnticoagulants for people hospitalised with COVID‐19 – Cochrane Library
Related: Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week.
Systematic Review: Prediction of good neurological outcome in comatose survivors of cardiac arrest.
7 Mar, 2022 | 00:40h | UTC
Commentary on Twitter
Predicting good neuro outcome in comatose cardiac arrest survivors? Look at
🧠 GCS motor 4/5
🧠 normal NSE
🧠 SSEP N20 wave amplitude > 4 μV or continuous EEG background without discharges
🧠 no diffusion restriction in cortex or deep grey matter on MRI
SR https://t.co/ixkMvErdux pic.twitter.com/GjeuTLgDlb— Intensive Care Medicine (@yourICM) March 4, 2022
Ten myths about albumin.
7 Mar, 2022 | 00:44h | UTCTen myths about albumin – Intensive Care Medicine (free for a limited period)
Commentary on Twitter
Albumin, 10 myths
1️⃣leaks into interstitium
2️⃣ ⬇️volume expansion vs artificial colloids
3️⃣ ⬇️AKI
4️⃣ sepsis: ⬆️survival
5️⃣ ⬆️diuretics effects
6️⃣RRT: ⬆️ fluid removal
7️⃣cirrhosis: ⬇️mortality
8️⃣TBI: ⬆️mortality
9️⃣correcting hypoalb ⬇️mortality
🔟 ⬆️NaCl
📎 https://t.co/nGOHOLYRqY pic.twitter.com/YroygQNNUk— Intensive Care Medicine (@yourICM) March 5, 2022
WSES/GAIS/WSIS/SIS-E/AAST global clinical pathways for patients with skin and soft tissue infections.
7 Mar, 2022 | 00:09h | UTC
WSES guidelines on blunt and penetrating bowel injury: diagnosis, investigations, and treatment.
7 Mar, 2022 | 00:11h | UTC
Arterial blood gas analysis: as safe as we think? A multicentre historical cohort study.
7 Mar, 2022 | 00:00h | UTCArterial blood gas analysis: as safe as we think? A multicentre historical cohort study – ERJ Open
[Preprint] RECOVERY trial shows Baricitinib reduces deaths in patients hospitalized with COVID-19.
4 Mar, 2022 | 10:09h | UTCNews Release: RECOVERY trial shows Baricitinib reduces deaths in patients hospitalised with COVID-19 – University of Oxford
Commentaries:
Arthritis drug reduces mortality in severe COVID-19, huge clinical trial finds – Science
Another life-saving Covid drug identified – BBC
Related:
WHO recommends two new drugs (Baricitinib and Sotrovimab) to treat COVID-19.
RCT: Baricitinib reduced mortality in hospitalized adults with COVID-19.
Randomized trial: Baricitinib plus remdesivir reduce recovery time in patients with COVID-19
Commentary from the author on Twitter (thread – click for more)
RECOVERY pre-print: Baricitinib
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis https://t.co/g0cNjaBzEL
— Martin Landray (@MartinLandray) March 3, 2022


